Filing Details
- Accession Number:
- 0001127602-21-013399
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-07 16:28:17
- Reporting Period:
- 2021-04-05
- Accepted Time:
- 2021-04-07 16:28:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1613103 | Medtronic Plc | MDT | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1560409 | Geoffrey Martha | 710 Medtronic Pkwy Ms Lc300 Minneapolis MN 55432 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2021-04-05 | 2,404 | $41.60 | 84,342 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2021-04-05 | 2,404 | $118.83 | 81,938 | No | 4 | S | Direct | |
Ordinary Shares | Acquisiton | 2021-04-05 | 9,308 | $55.32 | 91,246 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2021-04-05 | 9,308 | $118.83 | 81,938 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2021-04-05 | 2,404 | $0.00 | 2,404 | $41.60 |
Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2021-04-05 | 9,308 | $0.00 | 9,308 | $55.32 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2022-10-29 | No | 4 | M | Direct | |
11,173 | 2023-07-29 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- This balance increased by 844 shares due to exempt transactions such as dividend reinvestment.
- This option to purchase 2,404 Medtronic ordinary shares for $41.60 per share, which was partially vested at the effective time of the Covidien acquisition, represents the conversion of an option to purchase 2,404 Medtronic Inc. common stock shares for $41.60 per share. This Medtronic plc stock option has the same terms and conditions as the original Medtronic Inc. stock option.
- This option to purchase 1,808 Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Covidien acquisition, represents the conversion of an option to purchase 1,808 Medtronic Inc. common stock shares for $55.32 per share. This Medtronic plc stock option has the same terms and conditions as the original Medtronic Inc. stock option.
- This option to purchase 20,481 Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Covidien acquisition, represents the conversion of an option to purchase 20,481 Medtronic Inc. common stock shares for $55.32 per share. This Medtronic plc stock option has the same terms and conditions as the original Medtronic Inc. stock option.